Cargando…

Association of Depression and Anxiety with Cardiac Structural and Functional Characteristics in Heart Failure with Reduced and Mildly Reduced Ejection Fraction

Heart failure and mental health conditions frequently coexist and have a negative impact on health-related quality of life and prognosis. We aimed to evaluate depression and anxiety symptoms and to determine the association between psychological distress and cardiac parameters in heart failure with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szabo, Timea Magdolna, Nagy, Előd Ernő, Kirchmaier, Ádám, Heidenhoffer, Erhard, Gábor-Kelemen, Hunor-László, Frăsineanu, Marius, Frigy, Attila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037637/ https://www.ncbi.nlm.nih.gov/pubmed/36961061 http://dx.doi.org/10.3390/clinpract13020036

Ejemplares similares

Total 25-Hydroxyvitamin D Is an Independent Marker of Left Ventricular Ejection Fraction in Heart Failure with Reduced and Mildly Reduced Ejection Fraction
por: Szabo, Timea Magdolna, et al.
Publicado: (2023)

Cor Triatriatum Sinister Presenting as Cardioembolic Stroke in a Young Woman
por: Szabo, Timea Magdolna, et al.
Publicado: (2022)

Serum Osteoprotegerin and Carotid Intima-Media Thickness Are Related to High Arterial Stiffness in Heart Failure with Reduced Ejection Fraction
por: Fehérvári, Lajos, et al.
Publicado: (2021)

Targeting Mediators of Inflammation in Heart Failure: A Short Synthesis of Experimental and Clinical Results
por: Szabo, Timea Magdolna, et al.
Publicado: (2021)

Electrocardiographic Changes Associated with Early Repolarization Pattern in Healthy Young Males
por: Frigy, Attila, et al.
Publicado: (2022)

Sympathetic activation in heart failure with reduced and mildly reduced ejection fraction: the role of aetiology
por: Urbancsek, Réka, et al.
Publicado: (2021)

Elevated Serum Cystatin C and Decreased Cathepsin S/Cystatin C Ratio Are Associated with Severe Peripheral Arterial Disease and Polyvascular Involvement
por: Nagy, Előd Ernő, et al.
Publicado: (2022)

Neuroinflammation and microglia/macrophage phenotype modulate the molecular background of post-stroke depression: A literature review
por: Nagy, Előd Ernő, et al.
Publicado: (2020)

Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
por: Miller, Robert J.H., et al.
Publicado: (2022)

The Prognostic Value of Anemia in Patients with Preserved, Mildly Reduced and Recovered Ejection Fraction
por: Pintér, Anita, et al.
Publicado: (2022)

Risk stratification in heart failure with mild reduced ejection fraction
por: Magrì, Damiano, et al.
Publicado: (2020)

Heart failure with mid-range or mildly reduced ejection fraction
por: Savarese, Gianluigi, et al.
Publicado: (2021)

High circulating osteoprotegerin levels are associated with non-zero blood groups
por: Nagy, Elod Erno, et al.
Publicado: (2016)

Elevated CA-125 as Humoral Biomarker of Congestive Heart Failure: Illustrative Cases and a Short Review of Literature
por: Frigy, Attila, et al.
Publicado: (2020)

The Prescription Pattern of Heart Failure Medications in Reduced, Mildly Reduced, and Preserved Ejection Fractions
por: Rastogi, Tripti, et al.
Publicado: (2022)

Breakthroughs in the treatment of heart failure with mildly reduced and preserved ejection fraction
por: Talha, Khawaja M., et al.
Publicado: (2022)

Long-Term Outcomes of Heart Failure Patients With Preserved, Mildly Reduced, and Reduced Ejection Fraction
por: Nagata, Takuya, et al.
Publicado: (2023)

Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction
por: Vergaro, Giuseppe, et al.
Publicado: (2023)

The prevalence and clinical significance of anemia in patients hospitalized with acute heart failure
por: Frigy, Attila, et al.
Publicado: (2017)

Mildly symptomatic heart failure with reduced ejection fraction: diagnostic and therapeutic considerations
por: Arvanitaki, Alexandra, et al.
Publicado: (2020)

Cardiovascular magnetic resonance phenotyping of heart failure with mildly reduced ejection fraction
por: Brown, Louise A E, et al.
Publicado: (2022)

Machine learning models in heart failure with mildly reduced ejection fraction patients
por: Zhao, Hengli, et al.
Publicado: (2022)

Vascular Dysfunction Predicts Future Deterioration of Left Ventricular Ejection Fraction in Patients with Heart Failure with Mildly Reduced Ejection Fraction
por: Kishimoto, Shinji, et al.
Publicado: (2021)

Proteomic profiling of epicardial fat in heart failure with preserved versus reduced and mildly reduced ejection fraction
por: Gao, Qian, et al.
Publicado: (2023)

Prevalence, Characteristics, Management and Outcomes of Patients with Heart Failure with Preserved, Mildly Reduced, and Reduced Ejection Fraction in Spain
por: Escobar, Carlos, et al.
Publicado: (2022)

Heart failure with reduced, mildly reduced, or preserved left ventricular ejection fraction: Has reasoning been lost?
por: Xanthopoulos, Andrew, et al.
Publicado: (2022)

Real-world comparative effectiveness of ARNI versus ACEi/ARB in HF with reduced or mildly reduced ejection fraction
por: Fu, Michael, et al.
Publicado: (2022)

Risk stratification according to diastolic function indices in heart failure patients with mildly reduced or reduced ejection fraction
por: Granot, Yoav, et al.
Publicado: (2023)

The clinical burden of newly diagnosed Heart failure among patients with Reduced, mildly Reduced, and preserved ejection fraction
por: Nichols, Gregory A., et al.
Publicado: (2023)

Sex differences in patients with heart failure and mildly reduced left ventricular ejection fraction
por: Liu, Zhican, et al.
Publicado: (2023)

Efficacy of guideline‐directed medical treatment in heart failure with mildly reduced ejection fraction
por: Zhang, Xinxin, et al.
Publicado: (2022)

Heart failure pharmacological treatments and outcomes in heart failure with mildly reduced ejection fraction
por: Stolfo, Davide, et al.
Publicado: (2023)

Machine Learning for Mortality Prediction in Patients With Heart Failure With Mildly Reduced Ejection Fraction
por: Tian, Pengchao, et al.
Publicado: (2023)

Heart Failure Across the Range of Mildly Reduced and Preserved Ejection Fraction in the United States
por: Greene, Stephen J., et al.
Publicado: (2023)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2023)

Healthcare resource utilization and costs among patients with heart failure with preserved, mildly reduced, and reduced ejection fraction in Spain
por: Escobar, Carlos, et al.
Publicado: (2022)

Association between class of foundational medication for heart failure and prognosis in heart failure with reduced/mildly reduced ejection fraction
por: Ito, Miyuki, et al.
Publicado: (2022)

Five‐year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort
por: Chen, Shiqun, et al.
Publicado: (2022)

Long‐term mortality after acute coronary syndromes among patients with normal, mildly reduced, or reduced ejection fraction
por: Furtado, Remo H.M., et al.
Publicado: (2022)

Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial
por: Solomon, Scott D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hkfgnnikui4madv2no8145arrk